Prognostic impact of c-MET status on overall survival of patients with advanced gastric cancer treated with standard chemotherapy: A Japanese multicenter collaborative retrospective study

被引：0
|
作者：
Kuboki, Y. [1 ]
Fuse, N. [1 ]
Kuwata, T. [2 ]
Shinozaki, E. [3 ]
Machida, N. [4 ]
Yuki, S. [5 ]
Kajiura, S. [6 ]
Yamanaka, T. [7 ]
Ochiai, A. [8 ]
Ohtsu, A. [7 ]
机构：
[1] Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Chiba, Japan
[2] Natl Canc Ctr Hosp East, Dept Pathol, Chiba, Japan
[3] Canc Inst Hosp JFCR, Dept Gastroenterol, Tokyo, Japan
[4] Shizuoka Canc Ctr, Dept Gastrointestinal Oncol, Shizuoka, Japan
[5] Hokkaido Univ Hosp, Dept Gastroenterol & Hepatol, Sapporo, Hokkaido, Japan
[6] Toyama Univ, Dept Internal Med 3, Toyama 930, Japan
[7] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Chiba, Japan
[8] Natl Canc Ctr, Dept Pathol, Res Ctr Innovat Oncol, Chiba, Japan
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2646
引用
收藏
页码：S635 / S635
页数：1
相关论文
共 50 条
  • [1] Prognostic impact of epidermal growth factor receptor status on overall survival of advanced gastric cancer patients treated with standard chemotherapy: A Japanese multicenter collaborative retrospective study
    Kadowaki, S.
    Fuse, N.
    Kuboki, Y.
    Kuwata, T.
    Nishina, T.
    Ooki, A.
    Goji, T.
    Yamanaka, T.
    Ochiai, A.
    Ohtsu, A.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S635 - S635
  • [2] Prognostic impact of HER2, EGFR, and c-MET status on overall survival of advanced gastric cancer patients
    Fuse, Nozomu
    Kuboki, Yasutoshi
    Kuwata, Takeshi
    Nishina, Tomohiro
    Kadowaki, Shigenori
    Shinozaki, Eiji
    Machida, Nozomu
    Yuki, Satoshi
    Ooki, Akira
    Kajiura, Shinya
    Kimura, Tetsuo
    Yamanaka, Takeharu
    Shitara, Kohei
    Nagatsuma, Akiko Kawano
    Yoshino, Takayuki
    Ochiai, Atsushi
    Ohtsu, Atsushi
    GASTRIC CANCER, 2016, 19 (01) : 183 - 191
  • [3] Prognostic impact of HER2, EGFR, and c-MET status on overall survival of advanced gastric cancer patients
    Nozomu Fuse
    Yasutoshi Kuboki
    Takeshi Kuwata
    Tomohiro Nishina
    Shigenori Kadowaki
    Eiji Shinozaki
    Nozomu Machida
    Satoshi Yuki
    Akira Ooki
    Shinya Kajiura
    Tetsuo Kimura
    Takeharu Yamanaka
    Kohei Shitara
    Akiko Kawano Nagatsuma
    Takayuki Yoshino
    Atsushi Ochiai
    Atsushi Ohtsu
    Gastric Cancer, 2016, 19 : 183 - 191
  • [4] Prognostic impact of human epidermal growth factor-2 (HER2) status on overall survival (OS) of advanced gastric cancer (AGC) patients (pts) treated with standard chemotherapy without trastuzumab as a first-line treatment: A Japanese multicenter collaborative retrospective study.
    Nishina, Tomohiro
    Fuse, Nozomu
    Kuwata, Takeshi
    Kadowaki, Shigenori
    Shinozaki, Eiji
    Machida, Nozomu
    Yuki, Satoshi
    Ooki, Akira
    Kajiura, Shinya
    Goji, Takahiro
    Yamanaka, Takeharu
    Sasaki, Takahide
    Shitara, Kohei
    Kuboki, Yasutoshi
    Yoshino, Takayuki
    Ochiai, Atsushi
    Ohtsu, Atsushi
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [5] Prognostic impact of response to second-line chemotherapy on overall survival of patients with advanced gastric cancer
    Kim, S.
    Hwang, M.
    Park, Y.
    Park, S.
    Kim, Y.
    Ryu, K.
    Lee, J.
    Park, Y.
    Kim, N.
    Park, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [6] Prognostic impact of the c-MET polymorphism on the clinical outcome in locoregional gastric cancer patients
    Sunakawa, Yu
    Wakatsuki, Takeru
    Yang, Dongyun
    Zhang, Wu
    Ning, Yan
    Stintzing, Sebastian
    Stremitzer, Stefan
    Yamauchi, Shinichi
    Sebio, Ana
    El-khoueiry, Rita
    Iqbal, Syma
    Barzi, Afsaneh
    Gerger, Armin
    Stotz, Michael
    Azuma, Mizutomo
    Watanabe, Masahiko
    Koizumi, Wasaburo
    Lenz, Heinz-Josef
    PHARMACOGENETICS AND GENOMICS, 2014, 24 (12): : 588 - 596
  • [7] Prognostic factors for survival in patients with advanced gastric cancer treated with chemotherapy.
    Mangas, Montserrat
    Carmona Bayonas, Alberto
    Sanchez Lorenzo, Maria Luisa
    Ramchandani, Avinash
    Garcia, Teresa
    Custodio, Ana B.
    Lorenzo Barreto, Jose Enrique
    Diaz Guardamino, Isabel Echavarria
    Diaz Serrano, Asuncion
    Maria Cano, Juana
    Azkarate, Aitor
    Longo, Federico
    Mugica, Maitane
    Sanchez, Rodrigo
    Serrano, Raquel
    Alvarez Mancenido, Felipe Jose
    Alsina, Maria
    Jimenez-Fonseca, Paula
    Garrido, Marcelo
    Gallego Plazas, Javier
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [8] Prognostic impact of HER2 and EGFR status on overall survival of advanced gastric cancer patients.
    Cuk, M.
    Gajanin, R.
    Kulic, M.
    Maric, R.
    Racic, M.
    Maric, V.
    Lalovic, N.
    Lukic, R.
    Kovacevic, M.
    Vasiljevic, M.
    Dukic, N.
    VIRCHOWS ARCHIV, 2015, 467 : S126 - S126
  • [9] Impact of the Prognostic Nutritional Index on the Survival of Japanese Patients with Hepatocellular Carcinoma Treated with Sorafenib: A Multicenter Retrospective Study
    Hatanaka, Takeshi
    Kakizaki, Satoru
    Uehara, Daisuke
    Nagashima, Tamon
    Ueno, Takashi
    Namikawa, Masashi
    Saito, Shuichi
    Hosonuma, Kenichi
    Suzuki, Hideyuki
    Naganuma, Atsushi
    Takagi, Hitoshi
    Sato, Ken
    Uraoka, Toshio
    INTERNAL MEDICINE, 2019, 58 (13) : 1835 - 1844
  • [10] Prognostic factors for survival of patients with advanced gastric cancer treated with cisplatin-based chemotherapy
    Jong Gwang Kim
    Baek-Yeol Ryoo
    Yeon Hee Park
    Bong-Seog Kim
    Tae-You Kim
    Young-Hyuck Im
    Yoon-Koo Kang
    Cancer Chemotherapy and Pharmacology, 2008, 61 : 301 - 307
12345